This inventor holds 1 USPTO granted patent. Top assignee: Cha University Industry-Academic Cooperation Foundation. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Innovations by Hwa Seon Koo
Introduction
Hwa Seon Koo is an innovative inventor based in Sejong, South Korea. He has made significant contributions to the field of reproductive health through his research and inventions. His work focuses on enhancing endometrial blood flow, which is crucial for successful implantation in fertility treatments.
Latest Patents
Hwa Seon Koo holds a patent for a composition comprising botulinum toxin or a salt thereof aimed at increasing endometrial blood flow rate. This composition is designed to improve implantation potential and may be beneficial in preventing or treating subfertility or infertility. The application of this composition directly to the endometrium can enhance blood flow and improve embryonic implantation potential. Given that botulinum toxin has been widely used for cosmetic purposes, the studies on human toxicity may be expedited, making this invention economically and industrially valuable.
Career Highlights
Hwa Seon Koo is affiliated with the Cha University Industry-Academic Cooperation Foundation, where he continues to advance his research in reproductive health. His work is pivotal in addressing challenges faced by patients with subfertility or infertility, particularly those experiencing repeated failures in embryonic implantation.
Collaborations
Hwa Seon Koo collaborates with notable colleagues, including Youn Jung Kang and Jung Jae Ko, who contribute to his research endeavors. Their combined expertise enhances the potential impact of their work in the field of reproductive health.
Conclusion
Hwa Seon Koo's innovative approach to improving endometrial blood flow through his patented composition represents a significant advancement in fertility treatments. His contributions are poised to make a meaningful difference for individuals facing challenges in conception.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile